- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00451841
Exhaled Breath Condensate pH in Patients With Cough Caused by Gastroesophageal Reflux
Cough is the most common complaint for which patients seek medical attention in the United States, accounting for approximately 1 billion dollars in health care expenses annually. Gastroesophageal reflux disease (GERD) is the sole cause of chronic cough in up to 20-40% of all cases. The majority of these patients with GERD-induced cough have no classic "heartburn" symptoms, so this important cause of cough can thus be difficult to detect.
Our hypothesis is that changes in exhaled breath condensate (EBC) pH can be used as a sensitive and non-invasive marker to identify subjects with cough caused by acid reflux.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Gastroesophageal reflux disease (GERD) is the sole cause of chronic cough in up to 20-40% of all cases, and majority of these patients with GERD-induced cough have no classic "heartburn" symptoms. This important cause of cough can thus be difficult to detect. Non-invasive radiologic tests for GERD such as barium swallow is imperfectly sensitive in subjects with GERD-induced cough. The 24 hour pH probe, which continuously monitors esophageal pH and can correlate cough events with reflux events, is considered to be the gold standard test. However, this test is expensive, invasive, and not universally available.
The goal of the current study is to compare simultaneous measurements of esophageal pH with exhaled breath condensate pH after cough episodes, in patients with symptomatic cough. The cause of cough will be determined by a standard protocol, which includes 24 hour pH probe studies, and assessment for asthma, upper airway causes and sinus disease, and medication effects. All subjects will undergo 24 hour pH monitoring. During this monitoring period, they press an event button on the pH recording device to indicate a cough episode. After six such events, they will immediately perform an EBC collection, and EBC pH will subsequently be analyzed. Differences between pH changes in the group with cough cause by GERD will be compared to pH measurements in the group with cough but no GERD, to determine the sensitivity and specificity of pH changes for discriminating between the two groups, and optimal threshold values for pH changes in EBC.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Worcester, Massachusetts, United States, 01655
- UMass Memorial Medical Center, University Campus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- age > 18 years old
- able to speak and read English
- chronic cough
Exclusion Criteria:
- Cigarette smoking within the past 6 months, or greater than 10 pack year history of prior smoking
- Any self-reported or clinically diagnosed form of active lung disease, including asthma and emphysema
- Symptoms of persistent rhinitis within the past three months
- Dysphagia
- Symptoms of acute viral upper respiratory tract infection or sinusitis within one month of entry into the study
- Pregnancy - based on self report
- Abnormal chest radiograph
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
1
Chronic cough caused by GERD
|
Subjects breath through the device to collect exhaled breath condensate
|
|
2
Chronic cough without GERD
|
Subjects breath through the device to collect exhaled breath condensate
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sensitivity of esophageal PH changes
Time Frame: 24 hours
|
Determine the sensitivity of esophageal PH changes between the group with GERD and the group without GERD.
|
24 hours
|
Collaborators and Investigators
Investigators
- Principal Investigator: Stephen Krinzman, MD, University of Massachusetts, Worcester
Publications and helpful links
General Publications
- Horvath I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E, Becher G, van Beurden WJ, Corradi M, Dekhuijzen R, Dweik RA, Dwyer T, Effros R, Erzurum S, Gaston B, Gessner C, Greening A, Ho LP, Hohlfeld J, Jobsis Q, Laskowski D, Loukides S, Marlin D, Montuschi P, Olin AC, Redington AE, Reinhold P, van Rensen EL, Rubinstein I, Silkoff P, Toren K, Vass G, Vogelberg C, Wirtz H; ATS/ERS Task Force on Exhaled Breath Condensate. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J. 2005 Sep;26(3):523-48. doi: 10.1183/09031936.05.00029705.
- Niimi A, Nguyen LT, Usmani O, Mann B, Chung KF. Reduced pH and chloride levels in exhaled breath condensate of patients with chronic cough. Thorax. 2004 Jul;59(7):608-12. doi: 10.1136/thx.2003.012906.
- Hunt J. Exhaled breath condensate pH: reflecting acidification of the airway at all levels. Am J Respir Crit Care Med. 2006 Feb 15;173(4):366-7. doi: 10.1164/rccm.2512001. No abstract available.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Respiratory Tract Diseases
- Respiration Disorders
- Gastrointestinal Diseases
- Stomach Diseases
- Gastroenteritis
- Intestinal Diseases
- Signs and Symptoms, Respiratory
- Esophageal Motility Disorders
- Deglutition Disorders
- Esophageal Diseases
- Esophagitis
- Peptic Ulcer
- Duodenal Diseases
- Gastroesophageal Reflux
- Esophagitis, Peptic
- Cough
Other Study ID Numbers
- H-12073
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cough
-
McMaster UniversityNot yet recruitingCough | Refractory Chronic Cough | Chronic Cough | Unexplained Chronic Cough | Cough Hypersensitivity SyndromeCanada
-
Tongji HospitalNot yet recruitingPostoperative Cough | Cough Hypersensitivity SyndromeChina
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruiting
-
University of MontanaUniversity of Colorado, Denver; Emory University; University of MelbourneNot yet recruitingRefractory Chronic Cough | Unexplained Chronic Cough | Chronic Cough (CC)United States
-
Hyfe IncRecruitingRefractory Chronic Cough | Unexplained Chronic Cough | Cough HypersensitivityUnited States
-
Assiut UniversityNot yet recruiting
-
Hubei Bio-Pharmaceutical Industrial Technological...Not yet recruiting
-
Shanghai Children's Medical CenterNot yet recruiting
-
University of LeedsKing's College Hospital NHS Trust; Royal Brompton & Harefield NHS Foundation... and other collaboratorsRecruitingChronic Cough (CC)United Kingdom
-
AstraZenecaCompleted
Clinical Trials on RTube Exhaled Breath Condensate Collection System
-
University of California, DavisNational Heart, Lung, and Blood Institute (NHLBI)CompletedUpper Respiratory Tract Infections, Asthma, Exhaled BreathUnited States
-
Jena University HospitalCompletedPneumonia, Ventilator-associatedGermany
-
National Heart Centre SingaporeCompleted
-
Gazi UniversityThe Scientific and Technological Research Council of TurkeyUnknownExhaled Breath Condensate
-
University of FloridaCompleted
-
The University of Texas Medical Branch, GalvestonTerminated
-
Inger Lise GadeAarhus University HospitalCompletedPneumocystis Pneumonia | Aspergillosis PneumoniaDenmark
-
Virginia Commonwealth UniversityCompleted
-
Institut PasteurBiogroup Laboratoire de biologie médicaleRecruiting
-
Eline C. B. EskesRecruiting